Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Pancreatic Cancer Non-resectable
Interventions
RADIATION

Carbon ion radiotherapy

Patients with locally advanced unresectable pancreatic cancer without invasion of gastrointestinal tract will received ablative carbon ion radiotherapy. The prescription dose for primary pancreatic lesion, positive lymph node, and retroperitoneal high-risk recurrence area is 67.5 Gy (RBE weighted dose) in 15 fractions for 3 weeks; Pancreatic primary lesion and positive lymph node SIB to 75 Gy (RBE weighted dose) in 15 fractions for 3 weeks.

Trial Locations (1)

201315

RECRUITING

Shanghai Proton and Heavy Ion Center, Shanghai

All Listed Sponsors
lead

Shanghai Proton and Heavy Ion Center

OTHER